Delfraissy JF - Search Results

1

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.

Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, Autran B, Delfraissy JF, McDermott DH, Murphy PM, Debré P, Théodorou I, Combadière C. Faure S, et al. Among authors: delfraissy jf. Science. 2000 Mar 24;287(5461):2274-7. doi: 10.1126/science.287.5461.2274. Science. 2000. PMID: 10731151

2

Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection.

Guergnon J, Dalmasso C, Broet P, Meyer L, Westrop SJ, Imami N, Vicenzi E, Morsica G, Tinelli M, Zanone Poma B, Goujard C, Potard V, Gotch FM, Casoli C, Cossarizza A, Macciardi F, Debré P, Delfraissy JF, Galli M, Autran B, Costagliola D, Poli G, Theodorou I, Riva A; GISHEAL Consortium. Guergnon J, et al. Among authors: delfraissy jf. J Infect Dis. 2012 Mar 1;205(5):718-24. doi: 10.1093/infdis/jir833. Epub 2012 Jan 11. J Infect Dis. 2012. PMID: 22238471

3

CCR5 delta32 deletion and reduced risk of toxoplasmosis in persons infected with human immunodeficiency virus type 1. The SEROCO-HEMOCO-SEROGEST Study Groups.

Meyer L, Magierowska M, Hubert JB, Mayaux MJ, Misrahi M, Le Chenadec J, Debre P, Rouzioux C, Delfraissy JF, Theodorou I. Meyer L, et al. Among authors: delfraissy jf. J Infect Dis. 1999 Sep;180(3):920-4. doi: 10.1086/314933. J Infect Dis. 1999. PMID: 10438395

4

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.

Meyer L, Magierowska M, Hubert JB, Rouzioux C, Deveau C, Sanson F, Debre P, Delfraissy JF, Theodorou I. Meyer L, et al. Among authors: delfraissy jf. AIDS. 1997 Sep;11(11):F73-8. doi: 10.1097/00002030-199711000-00001. AIDS. 1997. PMID: 9302436

5

Pregnancy and progression to AIDS: results of the French prospective cohorts. SEROGEST and SEROCO Study Groups.

Saada M, Le Chenadec J, Berrebi A, Bongain A, Delfraissy JF, Mayaux MJ, Meyer L. Saada M, et al. Among authors: delfraissy jf. AIDS. 2000 Oct 20;14(15):2355-60. doi: 10.1097/00002030-200010200-00017. AIDS. 2000. PMID: 11089624

6

Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.

Laurichesse JJ, Persoz A, Theodorou I, Rouzioux C, Delfraissy JF, Meyer L. Laurichesse JJ, et al. Among authors: delfraissy jf. HIV Med. 2007 May;8(4):213-9. doi: 10.1111/j.1468-1293.2007.00455.x. HIV Med. 2007. PMID: 17461848 Free article.

7

Clinical and biological characteristics of human immunodeficiency virus-infected and uninfected intravascular drug users in Ho Chi Minh City, Vietnam.

Follézou JY, Lan NY, Lien TX, Lafon ME, Tram LT, Hung PV, Aknine X, Lowenstein W, Ngai NV, Theodorou I, Delfraissy JF, Debré P, Fleury HJ, Barré-Sinoussi F, Chi NH. Follézou JY, et al. Among authors: delfraissy jf. Am J Trop Med Hyg. 1999 Sep;61(3):420-4. doi: 10.4269/ajtmh.1999.61.420. Am J Trop Med Hyg. 1999. PMID: 10497983

8

A highly virulent variant of HIV-1 circulating in the Netherlands.

Wymant C, Bezemer D, Blanquart F, Ferretti L, Gall A, Hall M, Golubchik T, Bakker M, Ong SH, Zhao L, Bonsall D, de Cesare M, MacIntyre-Cockett G, Abeler-Dörner L, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C; Netherlands ATHENA HIV Observational Cohort†; BEEHIVE Collaboration†. Wymant C, et al. Science. 2022 Feb 4;375(6580):540-545. doi: 10.1126/science.abk1688. Epub 2022 Feb 3. Science. 2022. PMID: 35113714 Free article.

9

CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients.

Guérin S, Meyer L, Theodorou I, Boufassa F, Magierowska M, Goujard C, Rouzioux C, Debré P, Delfraissy JF; SEROCO/HEMOCO Study Group. Guérin S, et al. Among authors: delfraissy jf. AIDS. 2000 Dec 1;14(17):2788-90. doi: 10.1097/00002030-200012010-00020. AIDS. 2000. PMID: 11125899 No abstract available.

10

HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.

Abravanel F, Raymond S, Pambrun E, Winnock M, Bonnard P, Sogni P, Trimoulet P, Dabis F, Salmon-Ceron D, Izopet J; ANRS CO13 HEPAVIH Study Group. Abravanel F, et al. PLoS One. 2012;7(11):e50289. doi: 10.1371/journal.pone.0050289. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23226258 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

531 results

Search Page